<p>ELI-002 2P is an investigational therapeutic cancer vaccine targeting solid tumors driven by G12D and G12R mutations in KRAS As of the April 25, 2023 data cut-off date, among the 22 evaluable
<p>Markets Strong Q1 earnings by several Wall Street giants seemed to run away with all the attention on Friday, but eventually it was the University of Michigan’s July consumer survey which dic
Leave a Comment